Prof. Miquel Àngel Fullana

Ponència	Biomarcadors en psicologia clínica: una recerca raonable o ignis fatuus?
Data	Divendres, 21 d'abril, 2023
Hora	16:05 - 16:50
Taula rodona 3	Precisió en psicologia clínica

Dr. Fullana is currently a clinical psychologist at the Hospital Clínic and a senior researcher at the Imaging of Mood and Anxiety-Related Disorders (IMARD) Group at August Pi i Sunyer Biomedical Research Institute (IDIBAPS), in Barcelona. He has been an associate professor at the School of Medicine, Autonomous University of Barcelona; clinical psychologist and postdoctoral researcher at the Institute of Neuropsychiatry and Addictions of the Parc de Salut Mar, Barcelona; Marie Curie postdoctoral researcher at the King's College Institute of Psychiatry, London; and visiting professor at the Department of Psychiatry, Columbia University, New York. Dr. Fullana specializes in studying and treating anxiety-related disorders and obsessive-compulsive disorder (OCD). His research interests include applying and evaluating cognitive-behavior therapy (CBT) and identifying its predictors and mechanisms of action at the clinical and neurobiological levels. His contributions include the identification of clinical, genetic, and neuroimaging variables associated with CBT in OCD and anxiety-related disorders. He has received continued funding for his research from various public and private institutions, has published more than 100 research articles, has made more than 50 oral presentations at international conferences, and has been awarded several international awards, including the “Career Development Leadership Award” from the Anxiety Disorders Association of America. He collaborates internationally with researchers from the Karolinska Institutet, Duke University, Columbia University, Purdue University, University of Leuven, and the University of Melbourne. He has been a member of the scientific committee of numerous international congresses, including being chair of the scientific committee of the European Association of CBT in 2022.